BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29777390)

  • 1. Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells.
    Liu J; Gao Q; Xie T; Liu Y; Luo L; Xu C; Shen L; Wan F; Lei T; Ye F
    Clin Exp Med; 2018 Aug; 18(3):399-411. PubMed ID: 29777390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.
    Poondla N; Chandrasekaran AP; Heese K; Kim KS; Ramakrishna S
    Biochem Biophys Res Commun; 2019 Apr; 512(1):60-65. PubMed ID: 30862357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro.
    Chen J; Sun X; Yang W; Jiang G; Li X
    Tumour Biol; 2010 Dec; 31(6):613-22. PubMed ID: 20623264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.
    Ivanov VN; Zhou H; Hei TK
    Cancer Res; 2007 Jun; 67(11):5397-407. PubMed ID: 17545621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
    Yoon MJ; Kang YJ; Kim IY; Kim EH; Lee JA; Lim JH; Kwon TK; Choi KS
    Carcinogenesis; 2013 Aug; 34(8):1918-28. PubMed ID: 23615398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
    Zhitao J; Long L; Jia L; Yunchao B; Anhua W
    Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas.
    Burton TR; Henson ES; Azad MB; Brown M; Eisenstat DD; Gibson SB
    Cell Death Dis; 2013 Apr; 4(4):e587. PubMed ID: 23579274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
    Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
    Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.
    Ding L; Yuan C; Wei F; Wang G; Zhang J; Bellail AC; Zhang Z; Olson JJ; Hao C
    Cancer Invest; 2011 Oct; 29(8):511-20. PubMed ID: 21877938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation.
    Sophonnithiprasert T; Nilwarangkoon S; Nakamura Y; Watanapokasin R
    Int J Oncol; 2015 Dec; 47(6):2188-96. PubMed ID: 26499766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
    Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS
    Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis.
    Han H; Xu B; Hou P; Jiang C; Liu L; Tang M; Yang X; Zhang Y; Liu Y
    Cell Biochem Biophys; 2015 Jun; 72(2):533-42. PubMed ID: 25577511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.
    French R; Hayward O; Jones S; Yang W; Clarkson R
    Mol Cancer; 2015 Dec; 14():209. PubMed ID: 26667821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway.
    Khan M; Bi Y; Qazi JI; Fan L; Gao H
    Mol Med Rep; 2015 Jan; 11(1):257-62. PubMed ID: 25333675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.